ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,211,723 | +48.7% | 614,850 | +125.0% | 0.00% | – |
| Q2 2023 | $2,833,188 | -38.0% | 273,210 | -51.6% | 0.00% | -100.0% |
| Q1 2023 | $4,570,656 | +809.7% | 564,976 | +1671.1% | 0.00% | – |
| Q4 2022 | $502,425 | -22.8% | 31,900 | -22.8% | 0.00% | – |
| Q3 2022 | $651,000 | +75.9% | 41,336 | +56.0% | 0.00% | – |
| Q2 2022 | $370,000 | -46.4% | 26,500 | -33.8% | 0.00% | – |
| Q1 2022 | $690,000 | +0.3% | 40,000 | -15.6% | 0.00% | – |
| Q4 2021 | $688,000 | -2.3% | 47,382 | +21.1% | 0.00% | – |
| Q3 2021 | $704,000 | -72.6% | 39,117 | -73.3% | 0.00% | – |
| Q2 2021 | $2,572,000 | -82.2% | 146,464 | -74.4% | 0.00% | -100.0% |
| Q1 2021 | $14,435,000 | +818.3% | 572,835 | +135.6% | 0.00% | – |
| Q4 2020 | $1,572,000 | +4971.0% | 243,098 | +1942.8% | 0.00% | – |
| Q3 2020 | $31,000 | -46.6% | 11,900 | -61.2% | 0.00% | – |
| Q4 2019 | $58,000 | +38.1% | 30,642 | -21.0% | 0.00% | – |
| Q3 2019 | $42,000 | -94.5% | 38,785 | -88.8% | 0.00% | – |
| Q2 2019 | $761,000 | +77.0% | 347,475 | +384.8% | 0.00% | – |
| Q1 2019 | $430,000 | -66.3% | 71,670 | +12.1% | 0.00% | – |
| Q2 2018 | $1,276,000 | +168.1% | 63,932 | +135.1% | 0.00% | – |
| Q1 2018 | $476,000 | -85.5% | 27,198 | -79.6% | 0.00% | -100.0% |
| Q4 2017 | $3,291,000 | +358.4% | 133,494 | +380.2% | 0.00% | – |
| Q3 2017 | $718,000 | -28.8% | 27,800 | -17.7% | 0.00% | -100.0% |
| Q1 2017 | $1,008,000 | – | 33,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |